Literature DB >> 17673820

Adult T-cell leukemia/lymphoma presenting with bilateral hearing loss: a case report.

Sung Ho Lee1, Peter H Wiernik.   

Abstract

A 44-yr-old Jamaican male who presented only with bilateral hearing loss was found to have hypercalcemia, which, upon further investigation, was found to be due to adult T-cell leukemia/lymphoma (ATLL) syndrome. This is the first case of ATLL presenting with bilateral auditory conduction hearing loss, which responded to combination chemotherapy along with alleviation of other manifestations of ATLL.

Entities:  

Mesh：

Year:  2007        PMID： 17673820     DOI： 10.1007/BF02685911

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.738


  21 in total

1.  [Intracranial and orbital extension of a nasal cavity adult T-cell leukemia: a case report].

Authors:  K Hayashi; T Anda; A Yasunaga; S Shibata; N Sadamori; M Kisikawa; N Tsuda
Journal:  No Shinkei Geka       Date:  1999-01

2.  Epidemiology of adult T-cell leukemia/lymphoma in Japan.

Authors:  K Tajima; S Tominaga
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

3.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

4.  Sexual transmission of human T-lymphotropic virus type I (HTLV-I).

Authors:  E L Murphy; J P Figueroa; W N Gibbs; A Brathwaite; M Holding-Cobham; D Waters; B Cranston; B Hanchard; W A Blattner
Journal:  Ann Intern Med       Date:  1989-10-01       Impact factor: 25.391

5.  Cerebral mass lesions associated with adult T-cell leukemia/lymphoma.

Authors:  C Kawasaki; H Ikeda; T Fukumoto
Journal:  Int J Hematol       Date:  1995-02       Impact factor: 2.490

Review 6.  Natural history of HTLV-I infection: relationship to leukemogenesis.

Authors:  A Manns
Journal:  Leukemia       Date:  1993-08       Impact factor: 11.528

7.  Adult T-cell leukemia/lymphoma with initial deafness.

Authors:  Y Harada; T Shirota; T Hayashi
Journal:  Int J Hematol       Date:  2000-01       Impact factor: 2.490

8.  Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.

Authors:  J A Sparano; P H Wiernik; M Strack; A Leaf; N Becker; E S Valentine
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

9.  Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries.

Authors:  G de-Thé; A Gessain; L Gazzolo; M Robert-Guroff; G Najberg; A Calender; M Peti; G Brubaker; A Bensliman; F Fabry
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205
View more
  1 in total

1.  Acute bilateral hearing loss in peripheral T-cell lymphoma.

Authors:  Kavi K Devulapalli; Lamont C Smith
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.